FAQ

What is the Mona Care product clinical follow-up study?

Time:2026-08-14

When a medical device enters the market, the journey of ensuring its safety and effectiveness does not end — it enters a new phase. For companies like Mona Care, which provides a wide range of life care and rehabilitation products, clinical follow-up studies serve as a critical bridge between regulatory approval and real-world patient outcomes. But what exactly is a clinical follow-up study, and how does it apply to products such as nursing beds, lower limb rehabilitation exoskeletons, and other care devices offered by Mona Care?

Understanding Clinical Follow-Up Studies

A clinical follow-up study, often referred to in regulatory frameworks as Post-Market Clinical Follow-up (PMCF), is a systematic process of collecting and evaluating clinical data from a medical device after it has been authorized for sale. The goal is to confirm that the device continues to perform safely and effectively when used in everyday clinical environments, across diverse patient populations and healthcare settings.

Unlike premarket clinical investigations, which are conducted under controlled conditions with a limited number of subjects, clinical follow-up studies capture what happens in the real world. They help identify rare adverse events, confirm long-term safety, and validate that the clinical benefits seen during initial testing hold up over months and years of routine use.

Why Clinical Follow-Up Matters for Mona Care Products

Mona Care's product range spans several categories that directly impact patient health and mobility. From electric nursing beds used in both hospitals and homes, to advanced exoskeleton robots designed for gait rehabilitation, every product interacts closely with the human body. This makes post-market clinical monitoring especially important.

There are several reasons why clinical follow-up studies are essential for these types of care products:

  • Long-term safety monitoring: Devices like nursing beds and exoskeletons are used over extended periods. A clinical follow-up study can detect wear-related issues, user comfort changes, or unexpected safety concerns that only emerge after prolonged use.
  • Diverse patient populations: Premarket studies often involve a relatively homogeneous group of participants. In real-world settings, products are used by elderly individuals, post-stroke patients, children with motor disabilities, and people with varying levels of caregiver support. Follow-up data helps confirm that benefits extend across all these groups.
  • Continuous product improvement: Feedback collected through clinical follow-up can inform design refinements, user interface improvements, and updates to training materials for caregivers and medical professionals.
  • Regulatory compliance: International standards such as ISO 14155 and guidelines from bodies like the International Medical Device Regulators Forum (IMDRF) emphasize the importance of post-market clinical data for maintaining market authorization and ensuring ongoing conformity with safety and performance requirements.

How Mona Care Conducts Clinical Follow-Up

Mona Care works in partnership with rehabilitation departments, neurology units, intensive care facilities, and home care providers to gather meaningful clinical data. The company's approach to clinical follow-up is built on several key principles:

  • Real-world data collection: Rather than relying solely on controlled laboratory settings, Mona Care collects feedback from actual clinical environments — hospitals, rehabilitation centers, nursing homes, and private residences — where products are used daily.
  • Structured feedback channels: Healthcare professionals, caregivers, and patients using Mona Care products can provide structured input on device performance, usability, and any adverse events encountered during routine use.
  • Integration with risk management: Data gathered through clinical follow-up feeds directly into the company's risk management process, allowing for timely identification of potential issues and implementation of corrective actions when needed.
  • Ongoing clinical evaluation: The clinical evidence file for each product is continuously updated with new findings, ensuring that the benefit-risk assessment remains current and that the product's labeling accurately reflects the latest clinical knowledge.

Key Products in Clinical Follow-Up

Several product categories in the Mona Care portfolio are subject to ongoing clinical follow-up, each with distinct monitoring objectives:

Nursing Beds

Mona Care's electric nursing beds — including the Electric Multifunction Rotating Nursing Bed — are used in welfare institutions and home care settings. Clinical follow-up for these products focuses on long-term mechanical reliability, pressure sore prevention outcomes, ease of use for caregivers, and patient comfort during extended bed rest. Features such as back lifting, leg adjustment, left and right turning, and in-bed toilet functionality are monitored to ensure they continue to meet the needs of both patients and caregivers over months and years of daily use.

Lower Limb Rehabilitation Exoskeletons

The lower limb rehabilitation exoskeleton lineup — including Bear Adult, Rabbit Kid, and Gait Assist — represents some of the most technologically advanced products in the Mona Care catalog. These devices, which are IEC 60601 certified for safety and reliability, are used in rehabilitation departments, neurology, and neurosurgery units. Clinical follow-up studies for exoskeletons track gait improvement metrics, patient adherence to training protocols, device durability under repetitive high-frequency use, and the consistency of torque output. For the Rabbit Kid model, which has been deployed in schools and children's hospitals in Hong Kong, follow-up data also captures outcomes specific to pediatric populations with lower limb motor function disorders.

Patient Transfer and Mobility Devices

The Hug Moving patient transfer device and the Walking Robot & Wheel Chair combination are designed to assist with safe patient mobility. Clinical follow-up for these devices centers on caregiver ergonomics, fall prevention outcomes, and the ease with which patients can be transferred between beds, chairs, and other surfaces without injury to either the patient or the caregiver.

Laser Pain Relief and Washing Robots

The B-CURE Laser Pain Relief device and the automated washing robot are also included in Mona Care's clinical follow-up program. For the laser therapy device, follow-up studies monitor pain reduction outcomes, treatment consistency, and any skin-related side effects. For the washing robot, the focus is on hygiene effectiveness, patient comfort, and the device's ability to reduce caregiver workload in daily bathing routines.

How Clinical Follow-Up Benefits Patients and Caregivers

The ultimate value of clinical follow-up studies lies in the tangible benefits they deliver to end users. For patients using Mona Care products, ongoing clinical monitoring means:

  • Greater confidence that the device they rely on has been validated in real-world conditions similar to their own.
  • Access to product improvements and updates informed by data collected from thousands of users.
  • Clearer instructions for use, refined through feedback from healthcare professionals and caregivers.

For caregivers — whether family members at home or professional staff in medical institutions — clinical follow-up data helps establish best practices for device usage, reduces the risk of injury during patient handling, and provides evidence-based guidance on integrating assistive devices into daily care routines.

The Role of Standards and Certifications

Mona Care's clinical follow-up activities are guided by internationally recognized standards. The company's walking robots, for instance, have received IEC 60601 certification, which addresses the safety and essential performance of medical electrical equipment. This certification is not a one-time achievement — it requires ongoing evidence that the device continues to meet safety benchmarks throughout its commercial life, and clinical follow-up data is a key component of maintaining that evidence.

Additionally, guidance from the International Medical Device Regulators Forum (IMDRF) outlines the circumstances under which post-market clinical follow-up studies should be conducted, the elements that a well-designed study should include, and how the resulting information should be used to update risk management files and clinical evaluation reports.

Conclusion

A clinical follow-up study is far more than a regulatory checkbox — it is a commitment to patient safety and product excellence that extends across the entire lifecycle of a medical device. For Mona Care, this commitment is woven into every product category, from nursing beds to lower limb rehabilitation exoskeletons. By continuously gathering, analyzing, and acting on real-world clinical data, Mona Care ensures that its products not only meet regulatory requirements but also genuinely improve the quality of life for patients and caregivers around the world.

Contact Us

模板文件不存在: ./template/pc/message_m.htm